2-Deoxy-2-fluoro-D-glucopyranose
≥95%
- Product Code: 103694
CAS:
29702-43-0
| Molecular Weight: | 182.15 g./mol | Molecular Formula: | C₆H₁₁FO₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00077527 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used primarily in medical imaging, particularly in positron emission tomography (PET) scans, it serves as a radiotracer to detect and monitor cancer. The compound is labeled with fluorine-18, making it highly effective in visualizing metabolic activity in tissues, which helps in identifying malignant cells. Additionally, it aids in assessing the effectiveness of cancer treatments by tracking changes in tumor metabolism over time. Its application extends to neurological studies, where it helps in diagnosing and monitoring brain disorders such as Alzheimer's disease by mapping glucose metabolism in the brain.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off White/Yellow Solid |
| Purity (%) | 94.5-100 |
| Solubility | 49.00-51.00 mg/ml, Water |
| Specific Rotation [A]20/D(C=1, Dil Ammonia Water) | +60.0 - +65.0 |
| Specific Rotation [A]20/D(C=1, Dil Ammonia Water) | 60.0 deg +65.0 deg |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $141.22 |
+
-
|
| 0.025 | 10-20 days | $336.24 |
+
-
|
| 0.100 | 10-20 days | $1,238.77 |
+
-
|
2-Deoxy-2-fluoro-D-glucopyranose
Used primarily in medical imaging, particularly in positron emission tomography (PET) scans, it serves as a radiotracer to detect and monitor cancer. The compound is labeled with fluorine-18, making it highly effective in visualizing metabolic activity in tissues, which helps in identifying malignant cells. Additionally, it aids in assessing the effectiveness of cancer treatments by tracking changes in tumor metabolism over time. Its application extends to neurological studies, where it helps in diagnosing and monitoring brain disorders such as Alzheimer's disease by mapping glucose metabolism in the brain.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :